Amgen Receives CPMP Positive Recommendation For European Union Regulatory Approval Of Aranesp(R)n Oncology Read more about Amgen Receives CPMP Positive Recommendation For European Union Regulatory Approval Of Aranesp(R)n Oncology
Amgen Announces Its Registration Statement on Form S-3 Has Been Declared Effective Read more about Amgen Announces Its Registration Statement on Form S-3 Has Been Declared Effective
Amgen Files Registration Statement In Connection With Its Zero-Coupon Convertible Notes Read more about Amgen Files Registration Statement In Connection With Its Zero-Coupon Convertible Notes
Aranesp Studies Explore Potential Of New Anemia Treatment Paradigms Read more about Aranesp Studies Explore Potential Of New Anemia Treatment Paradigms
Amgen Stockholders Approve Issuance of Shares in Connection with Immunex Acquisition Read more about Amgen Stockholders Approve Issuance of Shares in Connection with Immunex Acquisition
Hassan Dayem Will Join Amgen as Senior Vice President and Chief Information Officer Read more about Hassan Dayem Will Join Amgen as Senior Vice President and Chief Information Officer
Amgen to Acquire Filgrastim and Pegfilgrastim in Europe from Roche Read more about Amgen to Acquire Filgrastim and Pegfilgrastim in Europe from Roche
Amgen's Oncology Pipeline Data Highlighted at Upcoming Scientific Meeting Read more about Amgen's Oncology Pipeline Data Highlighted at Upcoming Scientific Meeting
National Kidney Foundation Introduces Plan to Track Patients in National Screening Program Read more about National Kidney Foundation Introduces Plan to Track Patients in National Screening Program
Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple Skeletal Sites in Early and Later Stage Postmenopausal Women Read more about Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple Skeletal Sites in Early and Later Stage Postmenopausal Women
